Table 1. WBC and Progenitor Cell... | American Society of Hematology

Table 1.

WBC and Progenitor Cell Kinetics During G-CSF Treatment (N = 20)

	Baseline	Day 2	Day 3	Day 4	Day 5	Day 6
WBC (/μL)	6,000	27,500^*	31,950^*	33,750^*	34,300^*	33,100^*
	(4,500-12,000)	(19,800-38,500)	(24,200-44,100)	(26,100-52,200)	(8,600-57,300)	(20,500-52,800)
CD34⁺ cells (/mL)	825	1,449	5,600^†	17,400^*	27,331^*	25,045^*
	(340-4.290)	(236-7,200)	(1,272-18,224)	(3,600-77,500)	(3,200-184,000)	(2,730-152,100)
CFU-GM (/mL)	61	245	643^*	3,935^*	6,288^*	6,420^*
	(0-390)	(0-900)	(0-9,800)	(1-14,250)	(10-38,000)	(10-32,000)

	Baseline	Day 2	Day 3	Day 4	Day 5	Day 6
WBC (/μL)	6,000	27,500^*	31,950^*	33,750^*	34,300^*	33,100^*
	(4,500-12,000)	(19,800-38,500)	(24,200-44,100)	(26,100-52,200)	(8,600-57,300)	(20,500-52,800)
CD34⁺ cells (/mL)	825	1,449	5,600^†	17,400^*	27,331^*	25,045^*
	(340-4.290)	(236-7,200)	(1,272-18,224)	(3,600-77,500)	(3,200-184,000)	(2,730-152,100)
CFU-GM (/mL)	61	245	643^*	3,935^*	6,288^*	6,420^*
	(0-390)	(0-900)	(0-9,800)	(1-14,250)	(10-38,000)	(10-32,000)

Values are expressed as the median with the range in parentheses.P values are in comparison to baseline values.

P < .001.

P < .01.